-
-
-
-
-
-
-
FDA clears PM’s Zyn to market as lower cancer risk than cigarettes in 20 variants
-
-
-
-
-
-
-
Philip Morris International Reports 2026 First-Quarter Results and Updates 2026 Full-Year Adjusted Diluted EPS Forecast for Currency Only;
-
-
-
-
-
-
-
Philip Morris International (PM) Reports In-line EPS, Beats on Revenue; Offers FY26 EPS Guidance
-
-
-
-
-
-
-
Philip Morris International Presents at 2025 Morgan Stanley Global Consumer & Retail Conference
-
-
-
-
-
-
-
Philip Morris earnings preview Q3: strong print expected amid Zyn momentum
-
-
-
-
-
-
-
Philp Morris earnings preview Q2: stronger print expected on smoke-free portfolio gains
-
-
-
-
-
-
-
UBS upgrades Philip Morris on margin improvement at Zyn and IQOS
-
1,216,204 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

